ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk

May 2, 2003

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012

Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget

October 1, 1982

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995